What does Health, Sciences and Technologies CONSULTING do?

Health, Sciences and Technologies CONSULTING is an IT company in Dilbeek. Private Limited, started on 12 August 2019, 1 establishment.

What is the address of Health, Sciences and Technologies CONSULTING?

The registered office of Health, Sciences and Technologies CONSULTING is located at Aardbeienstraat 13, 1700 Dilbeek.

Is Health, Sciences and Technologies CONSULTING still active?

Yes. According to the CBE (29 September 2026) Health, Sciences and Technologies CONSULTING is active, legal situation “Normale toestand”, started on 12 August 2019.

Is Health, Sciences and Technologies CONSULTING registered on Peppol?

Yes, Health, Sciences and Technologies CONSULTING is registered on the Peppol network with ID 0208:0732525588.

What is the enterprise number of Health, Sciences and Technologies CONSULTING?

The enterprise number of Health, Sciences and Technologies CONSULTING is BE0732525588.

Is Health, Sciences and Technologies CONSULTING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 August 2019; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Health, Sciences and Technologies CONSULTING make in 2025?

Health, Sciences and Technologies CONSULTING recorded a loss after taxes of € 17,075 in financial year 2025.

What is the revenue of Health, Sciences and Technologies CONSULTING?

As a small company, Health, Sciences and Technologies CONSULTING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -9,511.

Health, Sciences and Technologies CONSULTING (Private Limited)

Q: When was Health, Sciences and Technologies CONSULTING founded?

Health, Sciences and Technologies CONSULTING was founded on 12 August 2019.

Dossier Health, Sciences and Technologies CONSULTING, printed on 29 September 2026 from databakkes.be/en/0732525588/health-sciences-and-technologies-consulting. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Health, Sciences and Technologies CONSULTING from Dilbeek, company number BE0732525588, closed financial year 2025 with a result of € -17,075 after tax. For that financial year Health, Sciences and Technologies CONSULTING recorded a gross margin of € -9,511 and equity of € 30,542. Compared with financial year 2024, the result moved from € 8,727 to € -17,075. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.

What it is worth Healthy

€ 30,542

▼ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -17,075

▼ still € 8,727 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 21,639

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 28,042.

People and assets in 2025

Vehicles and equipment

€ 3,235

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 76,770

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 24,556

▲ € 20,524 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -14,899 Gross margin 2022: € -14,899 First fiscal year in the series	€ 17,953 Gross margin 2023: € 17,953 ▲ € 32,852 vs 2022 (€ -14,899) Favourable step	€ 16,347 Gross margin 2024: € 16,347 ▼ 9% vs 2023 (€ 17,953) Unfavourable step	€ -9,511 Gross margin 2025: € -9,511 ▼ € 25,858 vs 2024 (€ 16,347) Unfavourable step	▼ € 25,858
Profit after taxes	€ -19,149 Profit after taxes 2022: € -19,149 First fiscal year in the series	€ 12,393 Profit after taxes 2023: € 12,393 ▲ € 31,542 vs 2022 (€ -19,149) Favourable step	€ 8,727 Profit after taxes 2024: € 8,727 ▼ 30% vs 2023 (€ 12,393) Unfavourable step	€ -17,075 Profit after taxes 2025: € -17,075 ▼ € 25,802 vs 2024 (€ 8,727) Unfavourable step	▼ € 25,802
Equity	€ 38,020 Equity 2022: € 38,020 First fiscal year in the series	€ 38,890 Equity 2023: € 38,890 ▲ 2% vs 2022 (€ 38,020) Favourable step	€ 47,617 Equity 2024: € 47,617 ▲ 22% vs 2023 (€ 38,890) Favourable step	€ 30,542 Equity 2025: € 30,542 ▼ 36% vs 2024 (€ 47,617) Unfavourable step	▼ 36%
Total debts	€ 15,244 Total debts 2022: € 15,244 First fiscal year in the series	€ 14,115 Total debts 2023: € 14,115 ▼ 7% vs 2022 (€ 15,244) Favourable step	€ 16,844 Total debts 2024: € 16,844 ▲ 19% vs 2023 (€ 14,115) Unfavourable step	€ 101,326 Total debts 2025: € 101,326 ▲ € 84,482 vs 2024 (€ 16,844) Unfavourable step	▲ € 84,482
Cash	€ 15,087 Cash 2022: € 15,087 First fiscal year in the series	€ 1,061 Cash 2023: € 1,061 ▼ 93% vs 2022 (€ 15,087) Unfavourable step	€ 23,178 Cash 2024: € 23,178 ▲ € 22,117 vs 2023 (€ 1,061) Favourable step	€ 21,639 Cash 2025: € 21,639 ▼ 7% vs 2024 (€ 23,178) Unfavourable step	▼ 7%
Retained profit	€ 35,520 Retained profit 2022: € 35,520 First fiscal year in the series	€ 36,390 Retained profit 2023: € 36,390 ▲ 2% vs 2022 (€ 35,520) Favourable step	€ 45,117 Retained profit 2024: € 45,117 ▲ 24% vs 2023 (€ 36,390) Favourable step	€ 28,042 Retained profit 2025: € 28,042 ▼ 38% vs 2024 (€ 45,117) Unfavourable step	▼ 38%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 11,523 Dividend 2023: € 11,523 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 11,523) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 76,770 Bank debt 2025: € 76,770 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 53,264 Balance sheet total 2022: € 53,264 First fiscal year in the series	€ 53,005 Balance sheet total 2023: € 53,005 Unchanged (€ 53,264) Unchanged	€ 64,461 Balance sheet total 2024: € 64,461 ▲ 22% vs 2023 (€ 53,005) Unchanged	€ 131,868 Balance sheet total 2025: € 131,868 ▲ 105% vs 2024 (€ 64,461) Unchanged	▲ 105%

Key figures of Health, Sciences and Technologies CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Health, Sciences and Technologies CONSULTING?

What happened at Health, Sciences and Technologies CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 2, 2026 New annual accounts for financial year 2025: loss of € 17,075 (▼ € 25,802 vs 2024). Source: NBB ↗
Aug 12, 2019 New establishment in Brussel. KBO
Aug 12, 2019 Start of the company according to the CBE. KBO

In short

From € 19,149 loss in 2022 to € 17,075 loss in 2025.

Paid € 5,417 in corporate taxes since 2022.

Best year ever: 2023, with € 12,393 profit.

Paid out € 11,523 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Health, Sciences and Technologies CONSULTING? We notify you, reason included.

Follow Health, Sciences and Technologies CONSULTING

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Aardbeienstraat 13

1700 Dilbeek

2.292.736.243

Duikerstraat 43

1020 Brussel

Active since 12 August 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0732.525.588

VAT number

BE 0732.525.588

Registered office

Aardbeienstraat 13, 1700 Dilbeek

Names & denominations

Health, Sciences and Technologies CONSULTING

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 August 2019

Peppol

Active · Active since 16 Dec 2025

Activities · NACE

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige dienstverlenende activiteiten op het gebied van informatie

Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗